DERMTECH, iNC.
11099 N. Torrey Pines Road, Suite 100
La Jolla, CA 92037
September 15, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
RE: | DermTech, Inc. |
| Registration Statement on Form S-3 |
| Filed September 8, 2020 |
| File No. 333-248642 |
| Request for Acceleration |
Ladies and Gentlemen:
With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of DermTech, Inc. (the “Company”), that the Securities and Exchange Commission accelerate the effective date of the Registration Statement to Thursday, September 17, 2020, at 4:05 p.m. Eastern Time, or as soon as practicable thereafter.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please call Jeremy Glaser or Jenna Stewart of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (858) 314-1515 or (858) 314‑1888, respectively, with any comments or questions regarding the Registration Statement.
Very truly yours, |
|
DermTech, Inc. |
|
|
/s/ Kevin Sun |
Kevin Sun |
Chief Financial Officer |
cc: | Jeremy Glaser, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. |
Jenna Stewart, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
